Using quantitative phosphopeptide sequencing of unstimulated versus stimulated primary murine Foxp3 + regulatory and Foxp3 − conventional T cells (Tregs and Tconv, respectively), we detected a novel and differentially regulated tyrosine phosphorylation site within the C1 domain of the guanine-nucleotide exchange factor CalDAG GEFI. We hypothesized that the Treg-specific and activation-dependent reduced phosphorylation at Y523 allows binding of CalDAG GEFI to diacylglycerol, thereby impacting the formation of a Treg-specific immunological synapse. However, diacylglycerol binding assays of phosphomutant C1 domains of CalDAG GEFI could not confirm this hypothesis. Moreover, CalDAG GEFI −/− mice displayed normal Treg numbers in thymus and secondary lymphoid organs, and CalDAG GEFI −/− Tregs showed unaltered in vitro suppressive capacity when compared to CalDAG GEFI +/+ Tregs. Interestingly, when tested in vivo, CalDAG GEFI −/− Tregs displayed a slightly reduced suppressive ability in the transfer colitis model when compared to CalDAG GEFI +/+ Tregs. Additionally, CRISPR-Cas9-generated CalDAG GEFI −/− Jurkat T cell clones showed reduced adhesion to ICAM-1 and fibronectin when compared to CalDAG GEFI-competent Jurkat T cells. Therefore, we speculate that deficiency in CalDAG GEFI impairs adherence of Tregs to antigen-presenting cells, thereby impeding formation of a fully functional immunological synapse, which finally results in a reduced suppressive potential.
Introduction
T cells need activation via their T cell receptor (TCR) through interaction with a peptide-loaded major histocompatibility complex (pMHC) expressed on the surface of an antigen-presenting cell (APC) in order to exert their respective effector functions [1] . TCR stimulation is focused at the interface between T cells and APCs at the immunological synapse (IS), which is composed of the central supramolecular activation cluster (cSMAC), surrounded by a peripheral (pSMAC) and distal SMAC (dSMAC). The SMACs are primarily comprised of microclusters of TCR/ CD3 molecules, integrin lymphocyte function-associated antigen-1 (LFA-1), and F-actin, respectively [2] . LFA-1 plays a dual role during T cell activation at the IS: First, interaction of LFA-1 with its ligand intercellular adhesion molecule-1 (ICAM-1) stabilizes the specifi c IS structure, allowing fi rm adhesion and stable contacts, and thereby sensitizing the TCR for very low quantities of pMHC [2] [3] [4] . Second, LFA-1 assists with integrin-mediated outsidein signaling, which serves as feedback for the T cell and delivers environmental information about chemical and mechanical characteristics; in this way, it supports intracellular signaling processes and also enables the deactivation and decomposition of the IS [5] . Activation of LFA-1 is facilitated in a three-step process. First, triggering of the TCR induces downstream signaling cascades, including the generation of the second messenger molecules Ca 2+ and DAG by phospholipase γ1 (Plcγ1). This results in activation of the small GTPase Rap1, a cellular switch regulating the transition from low to intermediate affi nity and clustering of LFA-1. Next, mechanical force generated through binding of LFA-1 to ICAM-1 promotes the fi nal conversion from the intermediate-to high-affi nity conformation of LFA-1 [6] [7] [8] .
Rap1 activation is initiated via one of its guanine-nucleotide exchange factors, which include C3G, the CDM family member DOCK4, and Epac, PDZ-GEF or CalDAG GEF family members [9] . GEFs support the release of GDP bound by Rap1 and thereby enable binding of GTP, which activates Rap1. Functionally, Rap1 was shown to mediate extracellular regulated kinase (ERK1/2) activation and integrin-dependent cell adhesion as well as chemokine-induced migration in leukocytes [9] .
The GEF CalDAG GEFI (Ca
2+
-and DAG-regulated guanine-nucleotide exchange factor I) is mainly expressed in the central nervous system, but it can also be found in cells of hematopoietic origin, such as T cells, platelets, and neutrophils [10] [11] [12] [13] . Guanine-nucleotide exchange activity towards Rap1 is regulated via Ca 2+ binding to the EF hand motifs of CalDAG GEFI [10] . However, the actual responsiveness of CalDAG GEFI towards the lipid second messenger DAG via its C1 domain remains controversial [10, [14] [15] [16] . In human T cells, it was reported that CalDAG GEFI is activated upon TCR stimulation in a Plcγ1-dependent manner [11] , and that it translocates to the cell membrane via interaction with polymerized actin, where it then colocalizes with Rap1 [14] . Besides TCR simulation, chemokine receptor activation such as the activation of CXCR4 via SDF-1α (CXCL12) has also been shown to trigger CalDAG GEFI in T cells [15] . Due to the specifi city towards Rap1, CalDAG GEFI function also plays a role in the mechanisms of adhesion and migration. Elevated expression of CalDAG GEFI in Jurkat T cells leads to increased adhesion [11] , and silencing of CalDAG GEFI in human primary T cells showed reduced adhesion following chemokine-mediated stimulation [15] . CalDAG GEFI-defi cient mice have diminished Rap1 activation and display impaired adhesion and migration properties in neutrophils. However, in CalDAG GEFI-defi cient platelets, Rap1 activation turned out to be delayed but robust later on, presumably owing to normal second-wave PKC-mediated activation [12, 13] . However, to the best of our knowledge, the role of CalDAG GEFI specifi cally in T cell subsets like regulatory T cells (Tregs) has not yet been thoroughly elucidated. Importantly, CalDAG GEFI expression has so far only been detected in human T cells and has been considered to be absent in T cells from mice [5, 12] .
Tregs play a crucial role in immune homeostasis and tolerance towards self and benign antigens and are defi ned by the expression of the master transcription factor Foxp3 [17] [18] [19] [20] [21] . Disruption of the Foxp3 locus leads to fatal autoimmunity in mice and humans, which manifests in the scurfy phenotype and immune dysregulation, polyendocrinopathy, enteropathy, and X-linked (IPEX) syndrome [22, 23] . It was already reported that the IS of Tregs and their counterparts, the conventional T cells (Tconv), differs with regard to the spatiotemporal distribution of some of the main molecular players like PKCθ [24] , and that signaling downstream of TCR ligation, e.g., Ca
2+ fl ux or phosphorylation of ERK, contrasts Tregs with Tconv [25] [26] [27] .
The present study is based on a recently performed comparative proteome and phosphoproteome analysis of primary murine Tregs and Tconv, which not only revealed differential expression of CalDAG GEFI within these two T cell subsets, but also identifi ed a novel phosphorylation site within CalDAG GEFI that is differentially regulated between Tregs and Tconv upon stimulation. While lipidbinding assays excluded an infl uence of the phosphorylation status of CalDAG GEFI on its DAG responsiveness, adhesion properties of CalDAG GEFI −/− Jurkat T cells were signifi cantly impaired. Phenotyping of the T cell compartment of CalDAG GEFI −/− mice displayed normal T cell development and homeostasis, and CalDAG GEFI −/− Tregs exhibited unaltered suppressive capacity in vitro. However, CalDAG GEFI −/− Tregs showed a slightly reduced suppressive capacity in vivo in mice, which might be due to impaired IS formation between Tregs and APCs based on compromised LFA-1 activation.
Materials and methods

Mouse strains
BALB/c were purchased from Harlan or Janvier. CalDAG GEF tm1Amg. (129S4-Sv/Jae) and Rag2 −/− (C57BL/6) mice were bred, housed and handled under specifi c pathogenfree conditions at the Helmholtz Centre for Infection Research (Braunschweig, Germany). Mice used in transfer colitis experiments were gender and age matched.
Antibodies and flow cytometry
Exclusion of dead cells was facilitated by LIVE/DEAD Fixable Dead Cell Stain (Invitrogen) prior to surface and intracellular staining or using propidium iodide in unfi xed samples. Foxp3 staining was carried out employing Foxp3 staining kit (eBiosciences). Fluorochrome-conjugated anti-CD3 (clone 17A2), anti-CD4 (clone RM4-5), anti-CD8 (clone 53-6.7), anti-CD25 (clone PC61.5), anti-CD62L (clone MEL-14), anti-CD44 (clone IM7), anti-CD103 (clone 2E7), anti-CD152 (clone UC10-4B9), anti-Foxp3 (clone FJK-16S), anti-human CD3 (clone OKT3), antihuman CD11a (clone HI111), and anti-human CXCR4 (clone 12G5) were purchased from Biolegend or eBiosciences. Data acquisition was performed using LSRII SORP Tconv were ex vivo isolated from single cell suspensions of pooled spleen and lymph node (LN) cells from BALB/c mice by MACS-based enrichment of CD4 + T cells using direct beads (L3T4, Miltenyi Biotec) followed by fl ow cytometry-based sorting to high purity. For proteome analysis, sorted T cell subsets were left unstimulated. For quantitative phosphopeptide sequencing, cells were either left unstimulated or stimulated by decoration with biotinylated anti-CD3 (clone145-2C11, BD Biosciences) and anti-CD28 (clone 37.51, BD Biosciences) and subsequent antibody crosslinking using streptavidin. Stimulation was stopped after 5 min with an excess of ice cold PBS and cells were further processed for liquid chromatographytandem mass spectrometry (LC-MS/MS) (further experimental details available on request).
Western blot
CD4 +
CD25
+ Tregs and CD4 + CD25 − Tconv were ex vivo isolated as described above. Primary T cell subsets or Jurkat T cells were lysed in RIPA lysis buffer (50 mM TrisHCl pH 8.0, 150 mM NaCl, 0.5% sodium deoxycholate, 1% NP40, 0.1 mM PMSF, Roche Complete Mini Protease Inhibitor), and total protein concentration was determined via BCA assay following the manufacturer's instructions (Thermo Scientifi c). PVDF membranes were blocked using blotting-grade milk powder and specifi c protein bands were detected via anti-Rasgrp2 (GTX108616, Genetex), anti-β-actin (AC-74, Sigma), or anti-phosphotyrosine (4G10, Upstate) with appropriate secondary antibodies and Super Signal West Dura Extended Duration Substrate (Thermo Scientifi c).
Protein expression, purification, and lipid-binding assay
For expression of recombinant GST-fused C1 domain, the coding sequence of the C-terminal region of murine CalDAG GEFI (corresponding to amino acids 495-553) was amplifi ed using forward primer 5ʹGAATTCATGGGCTTCGTACACAACTTC, reverse primer 5ʹCTCGAGCTGGGCGCGGCGACA, and Phusion Flash II DNA polymerase. The PCR product was digested with EcoRI/XhoI and subcloned into pGEX-4T-1, and the fi nal construct was verifi ed by sequencing. Phosphomutant C1 constructs were generated utilizing the Q5 ® Site-Directed Mutagenesis Kit (NEB) (Y523D: forward primer 5ʹCCTGGGCATCGACAAGCAGGG, reverse primer 5ʹATCAGAGCTTTGCAGTGGC; Y523F: forward primer 5ʹCTGGGCATCTTCAAGCAGGGC, reverse primer 5ʹGATCAGAGCTTTGCAGTGG) according to the manufacturer's instructions. For expression, the respective plasmids were transformed into Escherichia coli BL21. At an optical density of 0.7-0.9 at 600 nm, 1 mM isopropylthio-β-galactoside was utilized for induction. Cells were lysed, recombinant proteins were purifi ed via GSH columns and dialyzed against PBS or PBS supplemented with 100 μM ZnCl 2 . Prior to lipid-binding assay, protein concentration was determined via BCA assay (Thermo Scientifi c), and 0.5 μg/ml of each protein was tested on membrane lipid PIP Strips (Echelon) following the manufacturer's instructions.
CRISPR-Cas9-mediated gene knock-out in Jurkat T cells
Single guide RNAs (sgRNA) targeting CalDAG GEFI in Jurkat T cells were generated utilizing the online tool http://crispr.mit.edu/ (Zhang Lab, MIT, 2015). Selected sgRNAs were cloned into pSpCas9(BB)-2A-GFP (Addgene plasmid no. 48138) via BbsI restriction site; pSpCas9(BB)-2A-GFP (PX458) was a gift from Feng Zhang [28] . Jurkat T cells (JE6) were cultured in RPMI (Gibco) supplemented with 10% of fetal calf serum (FCS, Biochrom). For transfection, Jurkat T cells were electroporated employing the Amaxa Cell Line Nucleofector V Kit and the Amaxa Nucleofector device. Forty-eight hours after nucleofection, single Jurkat T cells were sorted into 96-well round bottom plates according to GFP expression. Single cell clones were expanded and tested for CalDAG GEFI expression via Western Blot.
Transduction of Jurkat T cells
To reexpress CalDAG GEFI in CalDAG GEFI −/− Jurkat T cell clones, lentiviral transduction was employed utilizing a modifi ed version of pRRL-PPT-SF-IRES-EGFP-PRE [29] . To allow effi cient and site-directed cloning of cDNAs upstream of the IRES sequence, a multiple cloning site (MCS) was introduced via overlapping PCR into pRRL-PPT-SF-IRES-EGFP-PRE [29] . Using the latter as a template, intermediate overlapping PCR products A and B were generated by using primer pairs MCS-For and RRL-ApaI-Rev (5ʹACTAGTTC GACGCGTCAAATCTAGATTATCGATACCGGTG ACGGATCCGCCC CTCTCCCTCCCCCCCCC and 5ʹCAGGTTTCCGGGCCCTCACATTGCCAAA) as well as MCS-Rev and RRL-PstI-For (5ʹCACCGGTATCGATA ATCTAGATTTGACGCGTCGAACTAGTCTGTCGGA GGAC TGGCGCGCCGAGTGAGG and 5ʹTAGCCTCG AGCTAGCTGCAGTAACGCCA), respectively. The fi nal product C was obtained by using overlapping products A and B as templates and fl anking primers RRL-PstI-For and RRL-ApaI-Rev. Finally, product C was subcloned, sequenced, and cloned into pRRL-PPT-SF-IRES-EGFP-PRE by ApaI and PstI restriction enzymes, resulting in pRRL-PPT-SF-newMCS-IRES-EGFP-PRE. For virus particle production, HEK293T cells were transfected with pRRL-PPT-SF-newMCS-i2-EGFPpre (empty vector back bone as control or vector containing subcloned human CalDAG GEFI) as well as packaging and envelope plasmids, employing calcium phosphate coprecipitation. Virus supernatant (VSN) was collected and concentrated via overnight centrifugation. For transduction, 2 × 10 6 Jurkat T cells were resuspended in 2 ml of enriched VSN and centrifuged for 30 min at 800 g. VSN was aspirated, and Jurkat T cells were cultured for 72 h in RPMI with 10% FCS before functional assays were performed. Transfection and transduction effi ciencies were assessed via GFP expression of HEK293T and Jurkat T cells, respectively.
Adhesion and migration assays
JE6 or CalDAG GEFI
−/− Jurkat T cells were adjusted to 1 × 10 5 cells/ml in RPMI with 10% FCS one day before the experiment. To study cell adhesion, on the experimental day, cells were stimulated with 5 μg/ml anti-CD3 (OKT3, BD Biosciences), 50 ng/ml PMA (Calbiochem), or 1 mM MnCl 2 for 30 min at 37 °C before adhesion on Fc-ICAM-1-coated (0.5 μg/well, R&D system) or Fibronectin-coated (1 μg/well, Roche) 96-well plates. 2 × 10 5 cells were seeded per well, and adhesion was allowed for 30 min at 37 °C. Unbound cells were removed by gently washing three times with HBSS (Biochrom AG), and the bound cell fraction was determined by counting using an ocular reticle. Bound cells were calculated as "% of input" in duplicates. Migration assays were performed using 5 μm polycarbonate fi lter transwells (Costar) coated with 20 μg/ml fi bronectin (1 h 37 °C, Roche). The lower transwell chamber was fi lled with either migration assay medium (RPMI, 1% bovine serum albumin fraction V, 10 mM HEPES pH 7.4) or migration assay medium supplemented with 200 ng/ml human SDF-1α (CXCL12, Biolegend). 2 × 10 5 cells were added to the upper chamber in 200 μl migration assay medium, and after 2.5 h at 37 °C, the number of migrated cells into the lower chamber was counted.
Phosphotyrosine analysis
Total CD4
+ T cells were isolated from spleen and LNs of CalDAG GEFI −/− , CalDAG GEFI +/− and CalDAG GEFI +/+ mice using mouse CD4 DirectBeads (L3T4) and the autoMACS separation system (Miltenyi Biotec). For stimulation, 1 × 10 6 cells were resuspended in complete RPMI (cRPMI; 10% FCS, 25,000 Units penicillin/25 mg streptomycin, 1 mM sodium pyruvate, 25 mM HEPES, 50 μM β-mercaptoethanol) supplemented with either 20 ng/ml PMA and 1 μg/ml ionomycin (both from Sigma) or 35 μM sodium pervanadate (Sigma), and incubated for 5 min at 37 °C. For anti-CD3/CD28 stimulation, cells were coated with 20 μg/ml biotinylated anti-CD3 (clone 145-2C11, BD Biosciences) and 10 μg/ml biotinylated anti-CD28 (clone 37.51, BD Biosciences), and crosslinking was induced for 5 min by addition of 10 μg/ml streptavidin in cRPMI. As stimulation controls, cells were either left on ice or incubated at 37 °C for 5 min in cRPMI. Following stimulation, cells were washed once in ice-cold PBS, and cell pellets were further processed for lysis and Western Blotting.
Phosflow staining for phospho-ERK1/2
Cells from spleen and LNs of CalDAG GEFI −/− , CalDAG GEFI +/− and CalDAG GEFI +/+ mice were stained for dead cells using the LIVE/DEAD Fixable Dead Cell Stain (Invitrogen) and subsequently for surface markers CD4 and CD25. Next, cells were coated with 10 μg/ml biotinylated anti-CD3 (clone 145-2C11, BD Biosciences) and 5 μg/ml biotinylated anti-CD28 (clone 37.51, BD Biosciences) for 15 min on ice. After removal of excess antibody, cells were pre-warmed to 37 °C and stimulation was initiated by addition of 10 μg/ml streptavidin in cRPMI. After indicated time points, cells were fi xed (BD Biosciences Phosfl ow Lyse/Fix) and permeabilized (BD Biosciences Phosfl ow Perm Buffer III) according to the manufacturer's protocol. Cells were stained intracellularly for ERK1/2 pT202/ pY204 or isotype control (both BD Biosciences Phosfl ow) and Foxp3 at 4 °C overnight.
In vitro suppression assay ) from CalDAG GEFI +/− mice were cocultured with pre-activated Tregs at indicated ratios in presence of T activator Beads (Life Technologies) in a ratio of one bead to two cells. On day four, CTV dilution was determined in living Tnaive by fl ow cytometry.
Transfer colitis
Freshly sorted Tregs and Tnaive from CalDAG GEFI −/− and CalDAG GEFI +/+ were washed in PBS, and a total of 4 × 10 5 cells was injected intraperitoneally into Rag2 −/− recipient mice in a ratio of 1:2 or 1:4 (Tregs:Tnaive). Body weight and health status of recipient mice was monitored biweekly over 10 weeks, and mice that lost >20% of initial body weight were sacrifi ced. For analysis, colon was rolled into a "Swiss roll", fi xed in 4% neutrally buffered formaldehyde, and embedded in paraffi n. Approximately 3-μm-thick sections were stained with hematoxylin/eosin (H&E) according to standard laboratory procedures. Slides were evaluated in a manner that was randomized and blinded to the experimental groups. A semi-quantitative score was applied for the marker's severity, lymphocytic invasion, epithelial hyperplasia, single cell apoptosis, and area involved. Each marker was graded from 0 to 3 as follows: Severity: 0 = no alteration, 1 = mild alteration, no serious disruption of the normal architecture, 2 = moderate alteration, but normal architecture of the epithelium still visible, 3 = severe infl ammation disturbing the entire epithelial structure, transmural. Lymphocytic infi ltration: 0 = no lymphocytes in lamina propria, 1 = few cells in lamina propria, not interfering with crypt structure, 2 = moderate amount of cells in lamina propria, increasing thickness of the crypts in max. 50%, 3 = transmural invasion of infl ammatory cells, exceeds 2. Hyperplasia: 0 = no alteration, 1 = up to 50% increase in crypt length, 2 = 50-100% increase in crypt length, moderate disturbance of crypt architecture, 3 = more than 100% increase in crypt length and marked disturbance of crypt architecture. Single cell apoptosis: 0 = no apoptosis observed, 1 = max. 1 per crypt, 2 = 2-3 per crypt, 3 = exceeds 2. Area involved: 0 = no alteration, 1 ≤ 40%, 2 = 40-70%, 3 ≥ 70%. The grades for these markers were added together for a total score of 0-15.
Statistical analysis
Prism software (GraphPad) was employed for generation of graphs and statistical analysis. Data points in scatter plots represent individual mice. If not stated otherwise, data are represented as mean ± SD. Statistical significance was determined via Mann-Whitney test or one-way ANOVA (Bonferroni's multiple comparison test or Kruskal-Wallis with Dunn's test for multiple comparison). *p < 0.05 was considered signifi cant with *p < 0.05, **p < 0.01, and ***p < 0.001.
Ethics
Animals were handled with appropriate care and welfare in accordance with good animal practice as defi ned by FELASA and the national animal welfare body GVSO-LAS under supervision of the institutional animal welfare offi cer, and all efforts were made to minimize suffering. Animal experiments were performed in accordance with institutional, state, and federal guidelines, and all animal experiments were approved by the Lower Saxony Committee on the Ethics of Animal Experiments as well as the responsible state offi ce (Lower Saxony State Offi ce of Consumer Protection and Food Safety) under the permit number 33.92-42502-04-13/1170.
Results
CalDAG GEFI is phosphorylated at Y523 and becomes dephosphorylated in Tregs upon TCR stimulation
CalDAG GEFI is known to have an impact on LFA-1 activation, showing responsiveness to both TCR and chemokine receptor triggering in human T cells [11, 14, 15] . However, the role of CalDAG GEFI in murine T cells and particularly in Tregs has not been studied so far, as no experimental evidence was available, showing that CalDAG GEFI is expressed in T cells from mice [5, 12] . Interestingly, we could detect CalDAG GEFI expression in ex vivo-isolated murine Tregs and Tconv during a recently performed comparative proteome study (manuscript under preparation), with a slightly higher expression level in Tconv (Fig. 1a) , a fi nding that could be confi rmed by Western Blot analysis (Fig. 1b) . Quantitative phosphopeptide sequencing of unstimulated versus stimulated Tregs and Tconv within the same study (van Ham et al., under preparation) even led to the identifi cation of a novel phosphorylation site within the C-terminal C1 domain of CalDAG GEFI at Y523 (Fig. 1c) . In resting Tregs, Y523 phosphorylation is slightly reduced as compared to resting Tconv. This difference becomes more pronounced upon TCR stimulation via crosslinked anti-CD3/CD28. Normalization to unstimulated Tconv shows that, while in Tconv Y523 phosphorylation is not responsive to TCR stimulation, the site gets strongly dephosphorylated in Tregs upon TCR triggering (Fig. 1c,d) . Thus, we confi rm here that CalDAG GEFI is expressed at detectable levels in murine T cell subsets and we could identify a novel phosphorylation site located in the C1 domain that is differentially regulated downstream of TCR signaling in primary murine Tregs and Tconv.
Phosphorylation status of Y523 does not affect DAG binding of CalDAG GEFI C1 domain
Although it is well established that generally C1 domains bind DAG, it is not clear whether the C1 domain of CalDAG GEFI is responsive to this lipid second messenger or any of its derivatives, such as PMA [14, [30] [31] [32] [33] . Recently, Czikora et al. showed that the C1 domain of human CalDAG GEFI binds DAG with very low affi nity, if it indeed binds at all, which they primarily attribute to four amino acid residues, namely N505, S506, A517, and I519 [16] . As Y523 is in close proximity to these crucial amino acid residues that comprise part of the DAG-binding pocket, we wondered whether the phosphorylation status, which affects the local charge of the evolutionary conserved C1 domain (Fig. 1e) , infl uences the DAG-binding ability of CalDAG GEFI.
To address this question, we cloned WT and two phosphomutant murine C1 domain constructs (Y523D and Y523F) into pGEX-4T-1, which adds an N-terminal GSTtag. Recombinant proteins were expressed in E. coli BL21, purifi ed via sepharose, and eluted to high purity. We applied equal amounts of purifi ed proteins to membrane lipid PIP Strips and detected protein binding to the spotted lipids via the GST-tag. For both mutated C1 domain versions, Y523D and Y523F, no DAG binding could be detected (Fig. 2a) . To support proper protein folding and stability, purifi ed C1 domains were dialyzed against ZnCl2-containing buffer; however, this treatment did not result in any DAG bind- ing of the phosphomutant versions of CalDAG GEFI C1 domain (Fig. 2b) . Therefore, we conclude that the observed differential phosphorylation of CalDAG GEFI Y523 in activated murine Tregs versus Tconv has no impact on CalDAG GEFI's sensitivity towards DAG.
CalDAG GEF −/− Jurkat T cells display slightly reduced TCR-induced adhesion to ICAM-1 and fibronectin but unaffected CXCR4-mediated migration
We generated two CalDAG GEFI Fig. 1a) . CalDAG GEFI is implemented into signaling pathways leading to LFA-1 activation, and it was previously shown that siRNA-based silencing of CalDAG GEFI expression in Jurkat T cells impairs cell adhesion [15] . Therefore, we tested adhesion of CalDAG GEFI-defi cient Jurkat T cell clones to ICAM-1 and fi bronectin in comparison to WT Jurkat T cells (JE6). As expected, unstimulated Jurkat Jurkat T cell clones were generated and tested for adhesion to ICAM-1 and fi bronectin as well as for migration on fi bronectin towards a chemoattractant. To rescue adhesion and/or migration abnormalities caused by CalDAG GEFI knock-out, both CalDAG GEFI −/− clones were reconstituted with wildtype CalDAG GEFI. Transduction with empty vector backbone served as treatment control. CalDAG GEFI-competent JE6 Jurkat T cells (JE6, white bars) or CalDAG GEFI −/− clones (no. 1, grey bars, and no. 2, black bars), untransduced (−), empty vector transduced (EV) or CalDAG GEFI reexpressing (WT), were either left unstimulated (unstim) or were stimulated via anti-CD3 (TCR) or MnCl2 (MnCl2) to induce adhesion to (a) ICAM-1 or (b) fi bronectin. (c) JE6 and CalDAG GEFI −/− clones, untransduced and transduced, were tested for migration without chemoattractant (medium) or towards SDF-1α. Data are pooled from three to fi ve independently performed experiments (mean ± SD) T cells showed very little adhesion, while nearly 60% of MnCl 2 -treated cells attached to ICAM-1 and fi bronectin irrespective of CalDAG GEFI defi ciency. Defi ciency of CalDAG GEFI led to signifi cantly reduced adhesion of TCR-triggered Jurkat T cells to both ICAM-1 and fibronectin (Fig. 3a,b) . Importantly, this phenotype could be reverted and rescued upon lentiviral reexpression of CalDAG GEFI (WT), while transduction with an empty control vector (EV) did not show any effect (Fig. 3a,b) . As it was already reported that LFA-1 activation is also required for CXCR4-mediated chemotaxis towards SDF-1α [34] , we next analyzed the impact of CalDAG (Fig. 3c) . However, in the presence of SDF-1α, both CalDAG GEFI −/− clones showed slightly diminished migration towards the chemokine, which could not be rescued by reexpression of CalDAG GEFI (Fig. 3c) , suggesting that this phenotype is clone-specifi c and not due to CalDAG GEFI defi ciency. To rule out the possibility that reduced adhesion and migration of CalDAG GEFI −/− clones are due to a reduction in surface expression of molecules that are involved in the respective signaling pathways, we analyzed protein abundance of CD3, the LFA-1 component CD11a, and the SDF-1α receptor CXCR4 on JE6 Jurkat T cells and both CalDAG GEFI −/− clones via fl ow cytometry. No significant differences in surface expression of CD3 and CXCR4 could be detected, and reexpression of CalDAG GEFI by lentiviral transduction had no infl uence on these molecules (Suppl . Fig. 1b,c,e) . However, differences could be observed with regard to CD11a, whose expression was signifi cantly reduced on clone no. 1 independent of the lentiviral reexpression (Suppl. Fig. 1d ). Taken together, we conclude that the drop in surface levels of CD11a is biologically irrelevant in the experimental settings used in the present study to analyze cell adhesion and chemotaxis, suggesting that loss of CalDAG GEFI impairs LFA-1-dependent adhesion of Jurkat T cells to ICAM-1 and fi bronectin following TCR triggering, whereas CXCR4-mediated migration remains unaffected.
CalDAG GEFI −/− mice display normal thymic T cell development and T cell homeostasis in secondary lymphoid organs
To address the role of CalDAG GEFI in murine T cells apart from the differential phosphorylation dynamics at Y523 in Tregs, we analyzed the T cell compartment within CalDAG GEFI −/− mice, which had been previously reported to have defects in platelet aggregation and neutrophil migration [12, 13] . In these initial studies, the lymphocyte count appeared to be normal, although the T cell compartment was not analyzed in detail [12] . Here, we fi rst analyzed the thymic T cell compartment and did not observe any overt effect of CalDAG GEFI defi ciency on T cell development, as double negative (DN), double positive (DP), CD8 single positive (CD8SP), and CD4 single positive (CD4SP) fractions were found in comparable frequencies in CalDAG GEFI −/− (KO), CalDAG GEFI +/− (HET), and CalDAG GEFI +/+ (WT) mice (Fig. 4a,b) . Similarly, no differences in frequencies of Foxp3 + and Foxp3 − CD4SP thymocyte subsets were found (Fig. 4a,b) , and also the two Treg precursors identifi ed as CD25 +
Foxp3
− or CD25 − Foxp3 + cells [35, 36] were present at comparable frequencies (data not shown). To assess the impact of CalDAG GEFI defi ciency on T cell homeostasis in the periphery, we analyzed the T cell compartment in pooled spleen and LNs and observed no differences in frequencies and absolute numbers of CD3 + T cell subsets in WT, HET, and KO mice (Fig. 4c,d , and data not shown). We conclude that deficiency of CalDAG GEFI affects neither thymic development nor peripheral homeostasis of T cells.
TCR downstream signaling is not affected by loss of CalDAG GEFI
It was previously reported that CalDAG GEFI affects ERK1/2 activation via Rap1, and, more specifi cally, it was shown that CalDAG GEFI reduces Elk1 activation and thereby limits ERK1/2 phosphorylation [9] [10] [11] 37] . As it is also known that Tregs display attenuated pERK1/2 levels as compared to Tconv [26, 27, 38] , we sought to address the role of CalDAG GEFI in TCR downstream signaling in ex vivo isolated Tregs and Tconv. To this end, we stimulated total CD4 + T cells from pooled spleen and LNs of CalDAG GEFI −/− (KO) or CalDAG GEFI +/+ (WT) mice via crosslinking of anti-CD3/CD28. At various time points following stimulation, we measured pERK1/2 via fl ow cytometry in Foxp3 + and Foxp3 − CD4 + T cell subsets. As expected, ERK1/2 phosphorylation was induced rapidly upon TCR ligation in both Tregs and Tconv, with Tconv reaching higher frequencies of pERK + cells when compared to Tregs (Fig. 5a,b) . Interestingly, CalDAG GEFI defi ciency did not affect ERK1/2 phosphorylation signifi cantly, neither in Tconv nor in Tregs, although a trend towards reduced ERK1/2 phosphorylation was observed in Tconv from CalDAG GEFI-defi cient mice (KO) (Fig. 5a ). To get a more global picture on the impact of CalDAG GEFI on TCR downstream signaling events, we next analyzed total tyrosine phosphorylation patterns by Western blotting in stimulated total CD4 + T cells ex vivo isolated from pooled spleen and LNs of CalDAG GEFI −/− (KO), CalDAG GEFI +/− (HET), and CalDAG GEFI +/+ (WT) mice. Isolated cells were stimulated via crosslinking anti-CD3/CD28 for 5 min, and stimulations using PMA/ ionomycin or sodium pervanadate were taken as positive controls. Unstimulated cells, which were either kept on ice or incubated in medium only, did not show any signs of tyrosine phosphorylation (Fig. 5b) . For none of the tested stimulation conditions (anti-CD3/CD28, PMA/ionomycin, or sodium pervanadate), major differences in tyrosine phosphorylation could be observed when KO, HET, and WT CD4 + T cells were compared, while expected alterations in overall signal strength according to the respective stimulation condition were apparent (Fig. 5b) . Thus, in our experimental setting, CalDAG GEFI is largely dispensable for TCR downstream signaling within primary murine CD4 + T cells.
CalDAG GEFI −/− Tregs display normal suppressive capacity in vitro
To assess the suppressive capacity of CalDAG GEFI −/− Tregs in vitro, CD4 + CD25 + Tregs were sorted from pooled spleen and LNs of CalDAG GEFI −/− or CalDAG GEFI +/+ mice and pre-activated in presence of IL-2 for 72 h on plate-bound anti-CD3/CD28. Subsequently, preactivated Tregs were cocultured with cell trace violetlabeled Tnaive (CTV) freshly isolated from CalDAG GEFI +/− mice in titrated ratios in presence of anti-CD3/ CD28-coated beads. At day 4 of the coculture, proliferation of Tnaive was measured by analyzing CTV dilution via fl ow cytometry. As expected, unstimulated Tnaive did not proliferate and showed a high CTV fl uorescence signal, while stimulated Tnaive in the absence of Tregs (0:1) proliferated substantially and diluted the dye progressively with every generation (Fig. 6a,b) . Upon addition of Tregs, a dose-dependent suppressive activity could be observed; however, no difference was apparent when Tregs from CalDAG GEFI −/− (KO) and CalDAG GEFI +/+ (WT) mice were directly compared (Fig. 6b) . Foxp3 staining on the day of analysis revealed equal survival and stability of CalDAG GEFI −/− and CalDAG GEFI +/+ Tregs in the respective cultures (data not shown). In conclusion, CalDAG GEFI defi ciency does not alter the suppressive ability of the Tregs in this APC-free in vitro system. However, since CalDAG GEFI plays a crucial role in LFA-1 activation and this integrin has an important function in the formation of the IS between T cells and APCs, the effect of CalDAG GEFI defi ciency on the suppressive capacity of Tregs might rely on their interaction with APCs.
CalDAG GEFI −/− Tregs are less capable to prevent intestinal inflammation in the transfer colitis model
To evaluate the suppressive capacity of CalDAG GEFI
−/−
Tregs under more physiological conditions, we chose the transfer colitis model, which is widely used to assess the suppressive capacity of Tregs. As expected, Rag2
−/− recipient mice receiving only Tnaive from CalDAG GEFI +/+ mice developed signs of colitis as evidenced by body weight loss starting from week 5 to 6 after T cell transfer (Suppl. Fig. 2a) , shortening of colon length (Suppl. Fig. 2b) , and a strong colonic pathology when compared to control mice receiving PBS only (Fig. 7) . Cotransfer of Tnaive with CD4 + CD25
+ Tregs at a ratio of 1 : 2 (Treg : Tnaive) resulted in a mild, but substantial amelioration of intestinal infl ammation regarding all parameters tested; however, no differences could be observed between Tregs isolated from CalDAG GEFI −/− (KO) or CalDAG GEFI +/+ (WT) mice (Fig. 7a, Suppl. Fig. 2a,b) . Accordingly, fl ow cytometric analysis of the T cell compartment in spleen, mLNs, and pLNs at the termination of the experiment did not show any differences in frequencies and absolute numbers of CD3 Next, we tested a lower ratio between Tregs and Tnaive (1:4), which has been used previously to detect subtle differences in the suppressive capacity of Treg subsets [39, 40] . Again, no differences with regard to body weight loss and colon length could be observed between the groups of mice receiving WT or KO Tregs (Suppl. Fig. 2c,d) . However, analysis of colonic pathology revealed that Tregs from CalDAG GEFI −/− mice had a slightly reduced suppressive capacity when compared to Tregs from CalDAG GEFI +/+ mice (Fig. 7b) . Together, we conclude that CalDAG GEFI defi ciency mildly affects the suppressive capacity of Tregs in vivo, with this phenotype only becoming apparent under weak suppression conditions.
Discussion
CalDAG GEFI is known to be important for human T cell adhesion [15] . Yet, it has not been investigated whether it also has a specifi c role in Foxp3 + Tregs. In the present study, we report on a novel phosphorylation site at Y523 within the C1 domain of mouse CalDAG GEFI, which upon stimulation is differentially regulated in ex vivo isolated murine Tregs when compared to Tconv. T cell development and homeostasis in secondary lymphoid organs, as well as ERK phosphorylation, are all unaffected in CalDAG GEFI −/− mice, and general signal transduction as seen by tyrosine phosphorylation patterns in total CD4 + T cells is also unchanged. Although CalDAG GEFI −/− Jurkat T cells showed normal chemotaxis behavior when compared to CalDAG GEFI-expressing Jurkat T cells, their adhesion to ICAM-1 and fi bronectin was impaired. These data correspond nicely to the assessment of the suppressive capacity of CalDAG GEFI −/− Tregs, which showed a normal inhibition of Tnaive proliferation in an APC-free in vitro assay, while a reduced suppressive capacity was observed at weak suppression conditions in vivo.
The CalDAG GEF family comprises four members, CalDAG GEFI-IV [12, [41] [42] [43] [44] . Although CalDAG GEFI is not the most prominent family member to be found in T cells, in a recently performed study, we identifi ed a novel phosphorylation site in CalDAG GEFI, which is located within its C-terminal C1 domain at Y523. Quantitative phosphopeptide sequencing comparing unstimulated and TCR-stimulated primary murine Tregs and Tconv revealed that Y523 phosphorylation is not affected by TCR stimulation in Tconv, whereas this site becomes strongly dephosphorylated upon TCR ligation in Tregs. As there is a growing body of evidence that TCR downstream signaling is distinctively organized in Tregs and Tconv [24, 26, 27, 38] , we speculated whether this differential phosphorylation fosters a differential activation of the two T cell subsets while also promoting the formation of a Treg-specifi c IS. The specifi c kinase responsible for phosphorylating CalDAG GEFI at Y523 and which phosphatase dephosphorylates it upon TCR ligation specifi cally in Tregs remain unidentifi ed, and further studies are needed for their identifi cation. In contrast to the other family members, CalDAG GEFI contains an atypical C1 domain, and it is currently debated whether this C1 domain can bind DAG itself, or simply DAG derivatives such as PMA [14, 16, [30] [31] [32] [33] 45] . Czikora et al. reported that the C1 domain of human CalDAG GEFI binds DAG with very low affi nity [16] . They could identify four critical amino acids within the C1 domain, which were essential for conformational stability of the binding pocket and its ability to retain a phorbol ester within this pouch. These exact amino acids are N505, S506, A517, and I519, which are replaced by N505T, S506Y, A517G, and I519L within the C1 domain of CalDAG GEFII and enable DAG responsiveness of this GEF [16] . The importance of the residue S506 was also previously addressed by Johnson et al.; however, they came to the conclusion that amino acid variations alone cannot account for the total loss of phorbol ester binding [45] . As the differentially phosphorylated Y523 localized into the loop B of the phorbol ester-binding pouch, we speculated that the negative charge of the phosphogroup also contributes to the inability to bind DAG, and that DAG responsiveness of CalDAG GEFI might be restored in Tregs upon removal of the phosphorylation after TCR triggering, leaving the hydrophobic tyrosine as a suitable environment for lipid binding. We generated a phosphomimetic mutant, Y523D, and a mutant representing the dephosphorylated state, Y523F, of the C1 domain, and tested for DAG binding via membrane lipid PIP strips. As all of the mutant C1 domains showed detectable binding, the functional role of the differentially regulated phosphorylation at Y523 in Tconv and Tregs might be related to activation of the pro- tein or interaction with other molecules, and needs to be addressed in future experiments.
We detected impaired adhesion of CalDAG GEFI −/− Jurkat T cell clones to ICAM-1 and fi bronectin following TCR stimulation, and this phenotype could be reverted by reexpression of CalDAG GEFI. The observed decline in adhesiveness following TCR triggering was not due to disturbed expression of CD3, which could have accounted for impaired stimulation resulting in decreased integrin activation. Furthermore, although we saw a signifi cant reduction in surface expression of CD11a on one of the CalDAG GEFI −/− Jurkat T cell clones, this observation was not infl uenced by reexpression of CalDAG GEFI. Therefore, we conclude that this phenotype was clone-specifi c and did not affect adhesion properties. Our fi nding that CalDAG GEFI plays a role in cell adhesion following TCR ligation is in line with published data showing CalDAG GEFI-mediated cell adhesion to ICAM-1 after SDF-1α stimulation [15] . In contrast to adhesion, chemokine-triggered migration of CalDAG GEFI −/− Jurkat T cells on fi bronectin was not affected. Although a slightly lower number of migrating cells was observed for CalDAG GEFI −/− clones in the present study, the difference did not reach statistical significance and was not infl uenced by reexpression of CalDAG GEFI. Thus, we speculate that CalDAG GEFI plays a role in adhesion and stable IS formation in murine T cells, but is dispensable for migration processes and hemisynapse formation [2] .
In CalDAG GEFI −/− mice, platelets display a reduced activation of Rap1, as well as defi cits in attachment and thrombus formation due to impaired α II β 3 and β 1 integrin activation [12, 13, 46] . Furthermore, neutrophils of this mouse line are defective in migration, which was also attributed to reduced Rap1, β 1 and β 2 integrin activation, as well as decreased integrin and L-selectin expression [13, 46] . Lymphocyte counts appeared to be normal [12] , and CalDAG GEFI −/− mice are lacking any obvious T cell-related phenotype. In line with these previously published general observations, more thorough examination of the T cell compartment within the thymus and secondary lymphoid organs confi rmed that T cell development and homeostasis are not disturbed in CalDAG GEFI −/− mice, suggesting that, in T cells, CalDAG GEFI defi ciency can be compensated for by other GEFs, like C3G [9, 47] , and might play non-redundant roles only in specifi c cell types and/or under certain perturbations.
Several in vitro studies proposed a role for CalDAG GEFI in ERK1/2 activation [10, 11, 48] . Kawasaki et al. found that overexpression of CalDAG GEFI in 293T cells inhibits Elk1 activation and assumed that this would lead to reduced phosphorylation of ERK1/2 further downstream [10] . In this case, knock-out of CalDAG GEFI should result in elevated pERK1/2 levels, although this hypothesis could not be confi rmed utilizing primary murine CD4 + T cells from CalDAG GEFI −/− , CalDAG GEFI +/− , and CalDAG GEFI +/+ mice in the present study. Generally, we could not detect a direct link between loss of CalDAG GEFI expression in murine CD4 + T cells and any impairment of signal transduction. A more recent publication described a negative feedback loop, in which ERK1/2 phosphorylates CalDAG GEFI at S394, which in turn auto-inhibits its GEF activity towards Rap1, ultimately also reducing phosphorylation of ERK1/2 [48] . However, in our phosphoproteomic approach, we could not identify any phosphorylation of S394, indicating that, under the applied stimulation conditions, ERK1/2 does not phosphorylate S394 in murine CD4 + T cells. CalDAG GEFI-defi cient Tregs showed a comparable suppressive capacity as Tregs from WT mice when tested in vitro, suggesting that the mere absence of this molecule does not dramatically affect the functional properties of these cells in an APC-free system. However, when CalDAG GEFI-defi cient Tregs were tested in vivo under conditions that allow detection of subtle differences in the suppressive capacity of Treg subsets [39, 40] , a slightly reduced inhibition of intestinal infl ammation was observed when compared to WT Tregs, indicating that CalDAG GEFI fi ne-tunes the functional properties of Tregs, most likely through the modulation of aggregate formation between Tregs and APCs, a process known to strongly affect the suppressive function of Tregs [49] .
In conclusion, our data suggest that CalDAG GEFI is dispensable for LFA-1 activation during migratory processes in CD4 + T cells, but is crucial for fi ne-tuning LFA-1 activation at the IS. Whether the differential phosphorylation at Y523 in Tconv and Tregs contributes to the formation a Tregs-specifi c IS needs to be addressed in future studies.
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